                               SEQUENCE LISTING

<110> ILLUMINA, INC.

<120> METHODS FOR PRODUCING STRANDED cDNA LIBRARIES

<130> 12957-130-228

<140> to be assigned
<141> on even date herewith

<150> 13/835,757
<151> 2013-03-15

<160> 6     

<170> PatentIn version 3.5

<210> 1
<211> 33
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 1
acactctttc cctacacgac gctcttccga tct                                    33


<210> 2
<211> 37
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 2
cggtctcggc attcctgctg aaccgctctt ccgatct                                37


<210> 3
<211> 39
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide


<220>
<221> modified_base
<222> (34)..(39)
<223> a, c, t, g, unknown or other

<400> 3
acactctttc cctacacgac gctcttccga tctnnnnnn                              39


<210> 4
<211> 39
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide


<220>
<221> modified_base
<222> (34)..(39)
<223> a, c, t, g, unknown or other

<220>
<223> 3'-phosphate

<400> 4
tcgcgagtta atgcaacgat cgtcgaaatt cgcnnnnnn                              39


<210> 5
<211> 33
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide


<220>
<223> 5'-phosphate

<400> 5
gcgaatttcg acgatcgttg cattaactcg cga                                    33


<210> 6
<211> 33
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 6
tcgcgagtta atgcaacgat cgtcgaaatt cgc                                    33


